Epigenetic Silencing of CCAAT/Enhancer-binding Protein δ Activity by YY1/Polycomb Group/DNA Methyltransferase Complex

被引:75
作者
Ko, Chiung-Yuan [2 ]
Hsu, Hey-Chi [6 ]
Shen, Meng-Ru [1 ]
Chang, Wen-Chang [1 ,2 ,3 ,4 ,5 ]
Wang, Ju-Ming [3 ,4 ,5 ]
机构
[1] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan
[2] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan
[3] Natl Cheng Kung Univ, Inst Biosignal Transduct, Tainan 70101, Taiwan
[4] Natl Cheng Kung Univ, Inst Bioinformat, Coll Biosci & Biotechnol, Tainan 70101, Taiwan
[5] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct Res, Tainan 70101, Taiwan
[6] Natl Taiwan Univ, Coll Med, Dept Pathol, Taipei 10002, Taiwan
关键词
D O I
10.1074/jbc.M804029200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human CCAAT/enhancer-binding protein delta (CEBPD) has been reported as a tumor suppressor because it both induces growth arrest involved in differentiation and plays a crucial role as a regulator of pro-apoptotic gene expression. In this study, CEBPD gene expression is down-regulated, and " loss of function" alterations in CEBPD gene expression are observed in cervical cancer and hepatocellular carcinoma. Suppressor of zeste 12 (SUZ12), a component of the polycomb repressive complex 2 (PRC2), silences CEBPD promoter activity, enhancing the methylation of exogenous CEBPD promoter through the proximal CpG islands. Moreover, this molecular approach is consistent with the opposite mRNA expression pattern between SUZ12 and CEBPD in cervical cancer and hepatocellular carcinoma patients. We further demonstrated that Yin-Yang-1 (YY1) physically interacts with SUZ12 and can act as a mediator to recruit the polycomb group proteins and DNA methyltransferases to participate in the CEBPD gene silencing process. Taking these results into consideration, we not only demonstrate the advantage of SUZ12-silenced CEBPD expression in tumor formation but also clarify an in vivo evidence for YY1-mediated silencing paths of SUZ12 and DNA methyltransferases on the CEBPD promoter.
引用
收藏
页码:30919 / 30932
页数:14
相关论文
共 61 条
[1]   The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia [J].
Agrawal, Shuchi ;
Hofmann, Wolf-Karsten ;
Tidow, Nicola ;
Ehrich, Mathias ;
van den Boom, Dirk ;
Koschmieder, Steffen ;
Berdel, Wolfgang E. ;
Serve, Hubert ;
Mueller-Tidow, Carsten .
BLOOD, 2007, 109 (09) :3895-3905
[2]   Association of GSTP1 CpG islands hypermethylation with poor prognosis in human breast cancers [J].
Arai, Takashi ;
Miyoshi, Yasuo ;
Kim, Seung Jin ;
Taguchi, Tetsuya ;
Tamaki, Yasuhiro ;
Noguchi, Shinzaburo .
BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 (02) :169-176
[3]   Transcription factor YY1 functions as a PcG protein in vivo [J].
Atchison, L ;
Ghias, A ;
Wilkinson, F ;
Bonini, N ;
Atchison, ML .
EMBO JOURNAL, 2003, 22 (06) :1347-1358
[4]   Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer [J].
Banks, RE ;
Tirukonda, P ;
Taylor, C ;
Hornigold, N ;
Astuti, D ;
Cohen, D ;
Maher, ER ;
Stanley, AJ ;
Harnden, P ;
Joyce, A ;
Knowles, M ;
Selby, PJ .
CANCER RESEARCH, 2006, 66 (04) :2000-2011
[5]   Stem cells, aging, and cancer: inevitabilities and outcomes [J].
Bell, DR ;
Van Zant, G .
ONCOGENE, 2004, 23 (43) :7290-7296
[6]   DNA methylation patterns and epigenetic memory [J].
Bird, A .
GENES & DEVELOPMENT, 2002, 16 (01) :6-21
[7]   EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer [J].
Adrian P. Bracken ;
Diego Pasini ;
Maria Capra ;
Elena Prosperini ;
Elena Colli ;
Kristian Helin .
The EMBO Journal, 2003, 22 (20) :5323-5335
[8]   cAMP-induced interleukin-10 promoter activation depends on CCAAT/enhancer-binding protein expression and monocytic differentiation [J].
Brenner, S ;
Prösch, S ;
Schenke-Layland, K ;
Riese, U ;
Gausmann, U ;
Platzer, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (08) :5597-5604
[9]   Hypermethylation of hMLH1, HPP1, p14ARF, p16INK4A and APC in primary adenocarcinomas of the small bowel [J].
Bruecher, Bjoern L. D. M. ;
Geddert, Helene ;
Langner, Cord ;
Hoefler, Heinz ;
Fink, Ulrich ;
Siewert, Joerg R. ;
Sarbia, Mario .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (06) :1298-1302
[10]   SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex [J].
Cao, R ;
Zhang, Y .
MOLECULAR CELL, 2004, 15 (01) :57-67